Sign in

CIK 0001372514

  • Non-accelerated filer
  • Smaller reporting company

KIORA PHARMACEUTICALS INC

Sign in to watch
Tickers
KPRX KPHMW
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980443284
Phone
+1 858-224-9600
Business address
169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
Former names
EYEGATE PHARMACEUTICALS INC

Securities

  • KPRX Common Stock Nasdaq
  • KPHMW Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-21 BALLAND THOMAS Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-21 TYLE PRAVEEN Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-21 CHANEY PAUL G Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-21 GOLDBERG MORTON Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-21 MALFROY-CAMINE BERNARD Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-14 Romano Sarah Interim CFO Purchase +20,000 22,500
2017-06-14 Romano Sarah Interim CFO Purchase · Warrants (right to buy) +20,000 20,000
2017-06-14 FROM STEPHEN President and CEO Purchase +60,000 259,965
2017-06-14 FROM STEPHEN President and CEO Purchase · Warrants (right to buy) +60,000 60,000
2017-06-02 CHANEY PAUL G Director Exercise or conversion +17,570 $0.65 $11K 41,229
2017-06-02 CHANEY PAUL G Director Exercise or conversion · Stock Option (right to buy) −17,570 0
2017-05-18 MANZO MICHAEL P. Vice President of Engineering Grant or award · Stock Option (right to buy) +8,000 8,000
2017-05-18 FROM STEPHEN President and CEO Grant or award · Stock Option (right to buy) +25,000 25,000
2017-05-15 MANZO MICHAEL P. Vice President of Engineering Exercise or conversion +7,285 $0.65 $5K 19,546
2017-05-15 MANZO MICHAEL P. Vice President of Engineering Exercise or conversion · Stock Option (right to buy) −7,285 0
2017-03-13 Ventech Capital II 10% owner Sale −4,419 $2.80 $12K 1,431,814
2017-03-07 Wirostko Barbara Chief Medical Officer Grant or award +8,700 $2.83 $25K 217,842
2017-03-06 GOLDBERG MORTON Director Sale −8,919 $3.00 $27K 9,441
2017-02-28 Wirostko Barbara Chief Medical Officer Grant or award +54,200 $2.59 $140K 209,142
2017-02-28 Wirostko Barbara Chief Medical Officer Grant or award +41,700 $2.60 $108K 41,700

Page 23 of 24 · 468 trades